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Background: This study aimed at assessing the number of red blood cell (RBC) units 
transfused at different types of medical institution and examining the characteristics of 
transfusion recipients.
Methods: We calculated and compared the number of transfusion recipients, total RBC 
units transfused, and RBC units transfused per recipient. Study data were extracted from 
insurance benefits reimbursement claims for RBC units at the Health Insurance Review & 
Assessment Service from 2006 to 2010. 
Results: Between 2006 and 2010, the number of recipients of RBC units increased from 
298,049 to 376,445, the number of RBC units transfused increased from 1,460,799 to 
1,841,695, and the number of RBC units transfused per recipient changed from 4.90 to 
4.89. The number of recipients aged ≥65 yr increased from 133,833 (44.9%) in 2006 to 
196,127 (52.1%) in 2010. The highest number of RBC units was transfused to patients 
with neoplastic diseases (31.9%) and diseases of the musculoskeletal system and con-
nective tissue (14.4%). More than 80% of the total number of RBC units were transfused 
at tertiary and general hospitals. However, this composition rate was slightly decreasing, 
with the composition rate for hospitals increasing from 12.6% to 16.3%.
Conclusions: This study revealed an increase in the number of RBC units transfused over 
a 5-yr period due to an increase in the number of transfused recipients, especially recipi-
ents aged ≥65 yr; moreover, the number of RBC units transfused differed based on medi-
cal institution type. These results provide fundamental data on RBC transfusions required 
for future research.
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INTRODUCTION
Blood and blood components are limited bioresources that are 
obtained through donation, similar to bone marrow and internal 
organs such as a kidney. Thus, the availability of blood compo-
nents is dependent on blood donation. In Korea, the number of 
blood component units supplied to medical institutions by 2 pri-
mary blood institutions annually increased from 3,647,730 units 
in 2006 to 4,528,412 units in 2010 [1]. 
 The increased demand for blood components is a worldwide 
phenomenon. In the United States, the number of whole blood 
and red blood cell (RBC) transfused units increased from 
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14,182,000 units in 2004 to 15,014,000 units in 2008 [2, 3]. In 
Canada, 833,020 RBC units were supplied to hospitals in 2008/ 
2009, which represented a 4.2% increase from the 799,556 units 
supplied in the previous year [4]. In Australia, the number of 
transfused RBC units increased from 768,919 units in 2007/2008 
to 795,892 units in 2009/2010 [5]. Since the rise in supply of 
blood units reflects a rise in transfusion demand, assessing the 
numbers of transfusion recipients and blood component units 
transfused at medical institutions can provide the data needed 
for developing plans to manage the demand for blood units.
 Some studies reporting on blood transfusion from the recipi-
ent’s perspective have associated the increase in transfusion 
demand with an aging and increasingly diverse population and 
an increase in therapeutic interventions [6-10]. However, few 
studies have examined the characteristics of transfusion recipi-
ents in Korea [11-13]. A better understanding of transfusion re-
cipients’ characteristics and the numbers of blood units trans-
fused at medical institutions will help predict future demand for 
blood components and provide a basis for developing strategies 
to meet those needs. Korea’s blood transfusion control policy 
primarily focuses on providing a stable and adequate supply of 
blood component units rather than controlling the demand [14]. 
However, controlling the demand itself or the rate of blood trans-
fusions performed is also needed to achieve a constant and suf-
ficient supply of blood units.
 The main components of donated whole blood are RBCs, 
platelets, and plasma. Since each component is used separately 
to treat completely different conditions, blood units transfused 
should be examined based on the blood component. Hence, 
this study focused on examining RBC component units. This 
study is aimed at examining changes in the number of RBC 
units transfused at differed types of medical institutions and 
characteristics of transfusion recipients, and providing funda-
mental data on RBC unit transfusions required for future re-
search.
METHODS
1. Study data
This study used the Health Insurance Review & Assessment 
Service (HIRA) insurance benefits reimbursement claims for 
RBC units transfused during the 5-yr period from 2006 to 2010. 
In Korea, the National Health Insurance (NHI) is a social insur-
ance program, and all citizens receive health benefits through 
the NHI or the public medical aid program.
 Medical insurance coverage extends to all medical institu-
tions. After providing recipients with the RBC units, medical in-
stitutions submit an insurance claim to the HIRA, which then 
makes a payment to the medical institution following the review 
and assessment of the claim. The claim data includes some 
variables such as gender, age, type of insurance, claimed medi-
cal institution, and primary discharge diagnosis of the trans-
fused patient.
 Of the 34 total blood unit types, we selected 10 RBC units for 
this study, e.g., packed RBCs (320 mL and 400 mL), washed 
RBCs (320 mL and 400 mL), leukocyte-reduced RBCs (320 mL 
and 400 mL), and other RBC unit types such as apheresis RBCs 
(190 mL). This study was approved by the Konkuk University 
Hospital institutional review boards (approval number: KUH 
1200024).
2. Variables 
In our analysis, we considered the following 5 variables: gender; 
age (0-14, 15-44, 45-64, or ≥65 yr of age); type of insurance 
(NHI, public medical aid, or other); type of medical institution, 
based on function and number of beds (tertiary hospital, gen-
eral hospital, hospital, long-term-care hospital, private clinic, 
dental hospital, or public health center); and primary discharge 
diagnosis.
 Based on the International Statistical Classification of Diseases 
Code, 9th edition (ICD-9), the following disease classifications 
were used for primary discharge diagnosis: certain infectious 
and parasitic diseases (A00-B99); neoplastic diseases (C00-D48); 
diseases of the blood and blood-forming organs, and certain dis-
orders involving the immune mechanism/system (D50-D89); dis-
eases of the nervous system (G00-G99); diseases of the circula-
tory system (I00-I99); diseases of the respiratory system (J00-
J99); diseases of the digestive system (K00-K93); diseases of the 
musculoskeletal system and connective tissue (M00-M99); dis-
eases of the genitourinary system (N00-N99); pregnancy, child-
birth, and puerperium (O00-O99); congenital malformations, 
deformations, and chromosomal abnormalities (Q00-Q99); in-
jury, poisoning, and other consequences resulting from external 
causes (S00-T98); and others. 
3. Measurements
A single transfusion recipient was represented by a single Ko-
rean identification number, regardless of the transfusion date 
(between January 1 and December 31). However, if one was 
transfused before and after one’s birthday on age group (four 
age groups), that person was regarded as one for each age 
group. Differences in the total number of transfusion recipients 
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(based on gender and age group, as well as on insurance type, 
institution type, and disease group types) were calculated.
 First, changes in the number of transfusion recipients based 
on gender and age groups were calculated for the 5-yr period. 
Second, the total number of RBC units transfused and the 
number of RBC units transfused per recipient were calculated 
based on the variables. Finally, the number of transfusion recipi-
ents and RBC units transfused per recipient were calculated 
based on age and disease groups and based on medical institu-
tion type and disease groups.
4. Data analysis 
Statistical analyses were performed using the SAS software (ver. 
9.1, SAS Institute, Cary, NC, USA). The Mantel-Haenszel chi-
square test was used to analyze changes in the number of RBC 
units transfused between years, as well as changes in other 
variables. A trend analysis of the number of RBC units trans-
fused per recipient between years, and of other variables was 
performed using an ANOVA test. A P value<0.05 indicated sta-
tistical significance.
RESULTS
1. Distribution of transfusion recipients
The total number of male transfusion recipients increased from 
131,487 in 2006 to 157,030 in 2010 (Fig. 1). Between 2006 and 
2010, the number of male transfusion recipients: increased from 
5,878 (4.5%) to 5,645 (3.6%) for the 0-14 age group; decreased 
from 19,572 (14.9%) to 18,184 (11.6%) for the 15-44 age group; 
increased from 52,188 (39.7%) to 58,454 (37.2%) for the 45-64 
age group; and increased from 54,221 (41.2%) to 75,053 (47.8%) 
for the ≥65 age group. 
 The total number of female transfusion recipients increased 
from 166,562 in 2006 to 219,415 in 2010 (Fig. 2). Between 2006 
and 2010, the number of female transfusion recipients did not 
change significantly (4,850, 2.9% vs. 4,829, 2.2%) for the 0-14 
age group; increased from 34,008 (20.4%) to 37,150 (16.9%) for 
the 15-44 age group; decreased from 48,420 (29.1%) to 56,636 
(25.8%) for the 45-64 age group; and increased from 79,612 
(47.8%) to 121,074 (55.2%) for the ≥65 age group.
2.  Total RBC units transfused and RBC units transfused per 
recipient
The total number of RBC units transfused increased from 1,460, 
799 units in 2006 to 1,841,695 units in 2010 (Table 1); however, 
the number of RBC units transfused per recipient did not signifi-
cantly change between 2006 (4.90 units) and 2010 (4.89 units; 
Table 2). The total number of RBC units transfused from 2006 
through 2010 increased from 49.2% to 51.7% (P <0.001) for fe-
male recipients, from 41.4% to 48.8% (P <0.001) for recipients 
≥65 yr of age, and from 82.0% to 87.1% (P <0.001) for recipi-
ents with health insurance. Additionally, more than 80% of the 
total RBC units were transfused at tertiary and general hospitals; 
however, this composition rate slightly declined by 2010, and 
the composition rate for hospitals increased from 12.6% to 
16.3% (P <0.001). 
 As for the total number of RBC units transfused by disease 
classification, the following average composition rates were cal-
culated for the 5-yr period: neoplastic diseases (31.9%); dis-
eases of the musculoskeletal system and connective tissue 
(14.4%); diseases of the circulatory system (11.2%); diseases of 
the digestive system (11.0%); injury, poisoning, and other con-
sequences resulting from external causes (9.6%; P <0.001; Ta-
ble 1). The average number of RBC units transfused per recipi-
Fig. 1. Male transfusion recipients of red blood cell units from 2006 
to 2010. 
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Fig. 2. Female transfusion recipients of red blood cell units from 
2006 to 2010.
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ent over the 5-yr period was 5.66 units for male recipients, 4.33 
units for female recipients (P =0.031), and 4.56 units for recipi-
ents aged ≥65 yr (P =0.018), which represented the age group 
with the lowest number of RBC units transfused. An increase in 
the number of RBC units transfused was observed for recipients 
with health insurance, and a decrease was observed for those 
with public medical aid (P =0.726). The average number of RBC 
units transfused per recipient based on medical institution was 
5.48 units for tertiary hospitals, 4.50 unit for general hospitals, 
and 3.64 units for hospitals (P =0.064). The average number of 
RBC units transfused per recipient based on disease classifica-
tion was 6.06 units for neoplastic diseases, 5.06 units for dis-
eases of the blood and blood-forming organs and certain disor-
ders involving the immune mechanism/system, and 4.73 units 
for diseases of the circulatory system (P =0.151; Table 2).
3.  Number of recipients and RBC units transfused per recipi-
ent by age group and disease classification
Over the 5-yr period, the highest average number of RBC units 
was transfused to the following age and disease groups: con-
Table 1. Number of red blood cell units (%) transfused from 2006 to 2010 by variables
Variables 2006 2007 2008 2009 2010 Average* P
Total 1,460,799 (100)  1,527,707 (100) 1,672,755 (100) 1,745,188 (100) 1,841,695 (100) 1,649,629 (100)
Gender Male 742,210 (50.8) 759,097 (49.7) 833,688 (49.8) 856,945 (49.1) 889,048 (48.3) 816,198 (49.5) <0.001
Female 718,589 (49.2) 768,610 (50.3) 839,067 (50.2) 888,243 (50.9) 952,647 (51.7) 833,431 (50.5)
Age (yr) 0-14 49,795 (3.4) 48,922 (3.2) 50,155 (3.0) 49,948 (2.9) 50,193 (2.7) 49,802 (3.0) <0.001
15-44 275,949 (18.9) 273,559 (17.9) 278,889 (16.7) 279,088 (16.0) 279,535 (15.2) 277,404 (16.8)
45-64 529,435 (36.2) 533,828 (34.9) 581,071 (34.7) 592,252 (33.9) 612,814 (33.3) 569,880 (34.6)
≥  65 605,249 (41.4) 671,209 (43.9) 762,027 (45.6) 823,697 (47.2) 898,957 (48.8) 752,228 (45.6)
Type of insurance Health insurance 1,197,970 (82.0) 1,269,400 (83.1) 1,422,822 (85.1) 1,503,627 (86.2) 1,604,859 (87.1) 1,399,736 (84.9) <0.001
Public medical aid 262,568 (18.0) 258,084 (16.9) 239,554 (14.3) 232,106 (13.3) 230,172 (12.5) 244,497 (14.8)
Others 261 (0.0) 224 (0.0) 10,379 (0.6) 9,455 (0.5) 6,664 (0.4) 5,397 (0.3)
Type of medical  
   institution
Tertiary hospital 645,852 (44.2) 654,230 (42.8) 728,026 (43.5) 768,967 (44.1) 792,863 (43.1) 717,988 (43.5)  <0.001
General hospital 587,831 (40.2) 608,488 (39.8) 671,731 (40.2) 669,473 (38.4) 710,528 (38.6) 649,610 (39.4)
Hospital 184,374 (12.6) 210,047 (13.7) 237,163 (14.2) 269,527 (15.4) 299,754 (16.3) 240,173 (14.6)
Long-term care Hospital 14,441 (1.0) 25,812 (1.7) 7,711 (0.5) 10,632 (0.6) 11,398 (0.6) 13,999 (0.8)
Private clinic 27,747 (1.9) 28,536 (1.9) 27,634 (1.7) 26,199 (1.5) 26,780 (1.5) 27,379 (1.7)
Public health center 209  (0.0) 193 (0.0) 142 (0.0) 132 (0.0) 125 (0.0) 160 (0.0)
Dental hospital 346 (0.0) 401 (0.0) 348 (0.0) 257 (0.0) 246 (0.0) 320 (0.0)
Disease  
   classification†
A00-B99 32,981 (2.3) 33,607 (2.2) 39,233 (2.3) 42,832 (2.5) 46,992 (2.6) 39,129 (2.4)  <0.001
C00-D48 481,492 (33.0) 494,747 (32.4) 539,224 (32.2) 544,966 (31.2) 570,680 (31.0) 526,222 (31.9)
D50-D89 55,338 (3.8) 55,745 (3.6) 58,020 (3.5) 64,872 (3.7) 66,963 (3.6) 60,188 (3.6)
G00-G99 10,384 (0.7) 11,408 (0.7) 11,825 (0.7) 11,655 (0.7) 12,721 (0.7) 11,599 (0.7)
I00-I99 170,304 (11.7) 174,668 (11.4) 189,270 (11.3) 190,664 (10.9) 197,560 (10.7) 184,493 (11.2)
J00-J99 39,845 (2.7) 44,153 (2.9) 51,815 (3.1) 57,913 (3.3) 62,675 (3.4) 51,280 (3.1)
K00-K93 174,765 (12.0) 176,762 (11.6) 183,258 (11.0) 185,738 (10.6) 183,648 (10.0) 180,834 (11.0)
M00-M99 179,229 (12.3) 206,566 (13.5) 240,966 (14.4) 268,181 (15.4) 292,731 (15.9) 237,535 (14.4)
N00-N99 76,384 (5.2) 79,082 (5.2) 90,154 (5.4) 98,976 (5.7) 104,114 (5.7) 89,742 (5.4)
O00-O99 35,842 (2.5) 39,800 (2.6) 36,380 (2.2) 37,160 (2.1) 41,802 (2.3) 38,197 (2.3)
Q00-Q99 13,228 (0.9) 12,815 (0.8) 14,776 (0.9) 13,598 (0.8) 14,270 (0.8) 13,737 (0.8)
S00-T98 140,316 (9.6) 144,060 (9.4) 161,629 (9.7) 168,499 (9.7) 180,518 (9.8) 159,004 (9.6)
Others 50,692 (3.5) 54,293 (3.6) 56,192 (3.4) 60,133 (3.4) 67,020 (3.6) 57,666 (3.5)
P-value by Mantel-Haenszel chi-square test.
*Average of the number of red blood cell units transfused (%) is calculated for the 5-yr period from 2006 to 2010; †Based on the International Statistical 
Classification of Diseases code (ICD-9), primary discharge diagnosis was classified as follows: A00-B99: Certain infectious and parasitic diseases, C00-D48: 
Neoplastic diseases, D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism/system, G00-G99: 
Diseases of the nervous system, I00-I99: Diseases of the circulatory system, J00-J99: Diseases of the respiratory system, K00-K93: Diseases of the digestive 
system, M00-M99: Diseases of the musculo-skeletal system and connective tissue, N00-N99: Diseases of the genitourinary system, O00-O99: Pregnancy, 
childbirth, and puerperium, Q00-Q99: Congenital malformations, deformations, and chromosomal abnormalities, S00-T98: Injury, poisoning, and other con-
sequences resulting from external causes.
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genital malformations deformations and chromosomal abnor-
malities (28.4%) and neoplastic diseases (17.7%) of the 0-14 
age group (P <0.001); neoplastic diseases (23.8%) and preg-
nancy, childbirth, and puerperium (19.1%) of the 15-44 age 
group (P <0.001); neoplastic diseases (31.0%) and diseases of 
the musculoskeletal system and connective tissue (19.0%) of 
the 45-64 age group (P <0.001); as well as diseases of the mus-
culoskeletal system and connective tissue (25.8%) and neoplas-
tic diseases (24.5%) of the ≥65 age group (P <0.001; Table 3). 
 Over the 5-yr period, the disease groups with the highest av-
erage number of RBC units transfused per recipient were: neo-
plastic diseases (9.33 units) and diseases of the blood and 
blood-forming organs and certain disorders involving the im-
mune mechanism/system (5.71 units), of the 0-14 age group 
(P =0.144); neoplastic diseases (6.52 units) and diseases of the 
blood and blood-forming organs and certain disorders involving 
the immune mechanism/system (5.87 units), of the 15-44 age 
group (P =0.328); neoplastic diseases (6.21 units) and diseases 
of the circulatory system (5.23 units), of the 45-64 age group 
(P =0.333); and neoplastic diseases (5.54 units) as well as con-
genital malformations, deformations, and chromosomal abnor-
malities (4.99 units), of the ≥65 age group (P =0.887; Table 4).
4.  Number of recipients and RBC units transfused per recipi-
ent by medical institution type and disease classification
The highest average percentage of recipients transfused with 
Table 2. Number of red blood cell units transfused per recipient from 2006 to 2010 by variables
Variables 2006 2007 2008 2009 2010 Average* P
Total 4.90 4.84 4.94 4.93 4.89 4.90
Gender Male 5.64 5.56 5.71 5.66 5.71 5.66 0.031
Female 4.31 4.29 4.36 4.34 4.35 4.33
Age (yr) 0-14 4.64 4.57 4.69 4.79 4.83 4.70 0.018
15-44 5.15 5.09 5.20 5.05 5.16 5.13
45-64 5.26 5.21 5.36 5.32 5.34 5.30
≥65 4.52 4.49 4.59 4.58 4.59 4.56
Type of insurance Health insurance 4.76 4.74 4.88 4.86 4.87 4.83 0.726
Public medical aid 5.36 5.17 4.95 4.89 4.92 5.06
Others 4.08 3.86 4.61 4.08 4.20 4.31
Type of medical  
   institution
Tertiary hospital 5.41 5.38 5.54 5.53 5.53 5.48 0.064
General hospital 4.51 4.43 4.54 4.50 4.53 4.50
Hospital 3.61 3.63 3.65 3.64 3.64 3.64
Long-term care hospital 3.47 3.42 2.85 2.92 2.98 3.20
Private clinic 3.12 3.13 3.17 3.05 3.15 3.12
Public health center 4.18 2.88 2.96 3.13 2.54 3.12
Dental hospital 5.09 3.89 3.66 3.28 3.52 3.86
Disease classification† A00-B99 4.16 4.09 4.04 3.92 4.07 4.04 0.151
C00-D48 6.01 5.96 6.13 6.09 6.09 6.06
D50-D89 5.27 5.07 4.88 5.01 5.08 5.06
G00-G99 3.33 3.38 3.46 3.42 3.38 3.39
I00-I99 4.59 4.53 4.81 4.85 4.84 4.73
J00-J99 3.37 3.36 3.37 3.39 3.39 3.38
K00-K93 4.64 4.50 4.52 4.34 4.49 4.49
M00-M99 3.63 3.62 3.72 3.76 3.73 3.70
N00-N99 3.80 3.74 3.86 3.83 3.86 3.82
O00-O99 3.53 3.63 3.62 3.56 3.62 3.59
Q00-Q99 3.31 3.23 3.73 3.72 3.56 3.51
S00-T98 4.13 4.12 4.15 4.03 4.11 4.11
Others 3.43 3.34 3.43 3.64 3.53 3.48
P value by ANOVA test.
*Average of the number of red blood cell units transfused per recipient is calculated for the 5-yr period from 2006 to 2010; †See Table 1 for disease classifi-
cation.
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Table 3. Number (%) of recipients of red blood cell units transfused from 2006 to 2010 by age group and disease classification†
Variables 2006 2007 2008 2009 2010 Average* P
0-14 yr Subtotal 10,728 (100) 10,696 (100) 10,695 (100) 10,336 (100) 10,474 (100) 9,960.4 (100) <0.001
A00-B99 278 (2.6) 222 (2.1) 222 (2.1) 247 (2.4) 226 (2.2) 239.0 (2.4) 
C00-D48 1,824 (17.0) 1,729 (16.2) 1,750 (16.4) 1,779 (17.2) 1,719 (16.4) 1,760.2 (17.7) 
D50-D89 524 (4.9) 547 (5.1) 541 (5.1) 540 (5.2) 546 (5.2) 539.6 (5.4) 
G00-G99 483 (4.5) 443 (4.1) 463 (4.3) 408 (3.9) 417 (4.0) 442.8 (4.4) 
I00-I99 348 (3.2) 391 (3.7) 382 (3.6) 377 (3.6) 358 (3.4) 371.2 (3.7) 
J00-J99 431 (4.0) 403 (3.8) 464 (4.3) 392 (3.8) 372 (3.6) 412.4 (4.1) 
K00-K93 355 (3.3) 392 (3.7) 379 (3.5) 339 (3.3) 365 (3.5) 366.0 (3.7) 
M00-M99 371 (3.5) 383 (3.6) 379 (3.5) 373 (3.6) 383 (3.7) 377.8 (3.8) 
N00-N99 154 (1.4) 165 (1.5) 175 (1.6) 181 (1.8) 182 (1.7) 171.4 (1.7) 
O00-O99 4 (0.0) 3 (0.0) 3 (0.0) 5 (0.0) 8 (0.1) 4.6 (0.0) 
Q00-Q99 2,917 (27.2) 2,977 (27.8) 2,847 (26.6) 2,686 (26.0) 2,726 (26.0) 2,830.6 (28.4)
S00-T98 681 (6.3) 640 (6.0) 602 (5.6) 599 (5.8) 547 (5.2) 613.8 (6.2)
Others 3,052 (28.4) 3,087 (28.9) 3,237 (30.3) 3,106 (30.1) 3,343 (31.9) 3165.0 (31.8)
15-44 yr Subtotal 53,580 (100) 53,745 (100) 53,674 (100) 54,087 (100) 55,334 (100) 55,480.8 (100) <0.001
A00-B99 1,198 (2.2) 1,130 (2.1) 1,100 (2.0) 1,119 (2.1) 1,134 (2.0) 1,136.2 (2.0)
C00-D48 13,072 (24.4) 12,955 (24.1) 13,302 (24.8) 13,183 (24.4) 13,435 (24.3) 13,189.4 (23.8) 
D50-D89 2,883 (5.4) 2,873 (5.3) 3,084 (5.7) 3,228 (6.0) 3,267 (5.9) 3,067.0 (5.5)
G00-G99 501 (0.9) 527 (1.0) 574 (1.1) 550 (1.0) 509 (0.9) 532.2 (1.0) 
I00-I99 3,887 (7.3) 3,611 (6.7) 3,696 (6.9) 3,524 (6.5) 3,457 (6.2) 3,635.0 (6.6) 
J00-J99 861 (1.6) 892 (1.7) 906 (1.7) 1,010 (1.9) 906 (1.6) 915.0 (1.6) 
K00-K93 7,432 (13.9) 7,340 (13.7) 7,185 (13.4) 7,145 (13.2) 6,982 (12.6) 7,216.8 (13.0) 
M00-M99 3,361 (6.3) 3,266 (6.1) 3,318 (6.2) 3,447 (6.4) 3,428 (6.2) 3,364.0 (6.1)
N00-N99 4,810 (9.0) 4,792 (8.9) 4,948 (9.2) 5,213 (9.6) 5,371 (9.7) 5,026.8 (9.1) 
O00-O99 10,098 (18.8) 10,915 (20.3) 9,980 (18.6) 10,201 (18.9) 11,680 (21.1) 10,574.8 (19.1) 
Q00-Q99 648 (1.2) 593 (1.1) 651 (1.2) 622 (1.1) 612 (1.1) 625.2 (1.1)
S00-T98 5,597 (10.4) 5,548 (10.3) 5,626 (10.5) 5,489 (10.1) 5,310 (9.6) 5,514.0 (9.9)
Others 1,787 (3.3) 1,767 (3.3) 1,865 (3.5) 1,919 (3.5) 1,933 (3.5) 1,854.2 (3.3)
45-64 yr Subtotal 100,608 (100) 102,484 (100) 108,493 (100) 110,905 (100) 115,090 (100) 113,976.0 (100) <0.001
A00-B99 2,159 (2.1) 2,294 (2.2) 2,463 (2.3) 2,600 (2.3) 2,815 (2.4) 2,466.2 (2.2)
C00-D48 33,763 (33.6) 34,151 (33.3) 35,722 (32.9) 35,928 (32.4) 37,291 (32.4) 35,371.0 (31.0) 
D50-D89 2,893 (2.9) 2,907 (2.8) 3,100 (2.9) 3,255 (2.9) 3,534 (3.1) 3,137.8 (2.8) 
G00-G99 778 (0.8) 856 (0.8) 870 (0.8) 841 (0.8) 934 (0.8) 855.8 (0.8) 
I00-I99 12,658 (12.6) 12,463 (12.2) 12,830 (11.8) 12,301 (11.1) 12,395 (10.8) 12,529.4 (11.0) 
J00-J99 2,529 (2.5) 2,549 (2.5) 2,675 (2.5) 2,901 (2.6) 2,998 (2.6) 2,730.4 (2.4) 
K00-K93 14,934 (14.8) 15,145 (14.8) 15,434 (14.2) 15,376 (13.9) 15,333 (13.3) 15,244.4 (13.4) 
M00-M99 18,441 (18.3) 19,915 (19.4) 21,868 (20.2) 23,410 (21.1) 24,569 (21.3) 21,640.6 (19.0) 
N00-N99 7,378 (7.3) 7,518 (7.3) 8,289 (7.6) 8,944 (8.1) 9,169 (8.0) 8,259.6 (7.2) 
O00-O99 54 (0.1) 39 (0.0) 57 (0.1) 59 (0.1) 63 (0.1) 54.4 (0.0) 
Q00-Q99 328 (0.3) 285 (0.3) 339 (0.3) 368 (0.3) 356 (0.3) 335.2 (0.3)
S00-T98 8,019 (8.0) 7,946 (7.8) 8,679 (8.0) 8,939 (8.1) 9,691 (8.4) 8,654.8 (7.6)
Others 3,798 (3.8) 3,783 (3.7) 4,136 (3.8) 4,314 (3.9) 4,443 (3.9) 4,094.8 (3.6)
≥65 yr Subtotal 133,833 (100) 149,536 (100) 165,968 (100) 179,513 (100) 196,127 (100) 150,445.6 (100) <0.001
A00-B99 4,288 (3.2) 4,571 (3.1) 5,914 (3.6) 6,564 (3.7) 7,825 (4.0) 5,832.4 (3.9) 
C00-D48 31,826 (23.8) 34,562 (23.1) 37,475 (22.6) 38,859 (21.6) 41,516 (21.2) 36,847.6 (24.5) 
D50-D89 4,236 (3.2) 4,703 (3.1) 5,195 (3.1) 5,763 (3.2) 6,039 (3.1) 5,187.2 (3.4) 
G00-G99 1,356 (1.0) 1,553 (1.0) 1,517 (0.9) 1,658 (0.9) 1,861 (0.9) 1,589.0 (1.1) 
(Continued to the next page)
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Table 3. (continued from the previous page) Number (%) of recipients of red blood cell units transfused from 2006 to 2010 by age group 
and disease classification†
Variables 2006 2007 2008 2009 2010 Average* P
≥65 yr I00-I99 20,263 (15.1) 22,156 (14.8) 22,438 (13.5) 23,184 (12.9) 24,525 (12.5) 22,513.2 (15.0) <0.001
J00-J99 8,018 (6.0) 9,285 (6.2) 11,328 (6.8) 12,811 (7.1) 14,237 (7.3) 11,135.8 (7.4) 
K00-K93 15,032 (11.2) 16,493 (11.0) 17,607 (10.6) 18,527 (10.3) 19,693 (10.0) 17,470.4 (11.6) 
M00-M99 27,177 (20.3) 33,456 (22.4) 39,237 (23.6) 44,754 (24.9) 49,610 (25.3) 38,846.8 (25.8) 
N00-N99 7,834 (5.9) 8,747 (5.8) 9,984 (6.0) 11,376 (6.3) 12,516 (6.4) 10,091.4 (6.7) 
O00-O99 0 (0.0) 1 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0.2 (0.0) 
Q00-Q99 90 (0.1) 97 (0.1) 111 (0.1) 124 (0.1) 117 (0.1) 107.8 (0.1)
S00-T98 19,709 (14.7) 20,830 (13.9) 24,035 (14.5) 25,979 (14.5) 29,232 (14.9) 23,957.0 (15.9)
Others 6,144 (4.6) 7,615 (5.1) 7,098 (4.3) 7,657 (4.3) 8,699 (4.4) 7,442.6 (4.9)
P value by Mantel-Haenszel chi-square test. The subtotal is not calculated as 100 in this table because the same person could get the red blood cell units 
with different diseases and age group change.
*Average of the number of recipients (%) of red blood cell units transfused from 2006 to 2010 by age group and disease classification; †See Table 1 for dis-
ease classification.
Table 4. Number of red blood cell units transfused per recipient from 2006 to 2010 by age group and disease classification†
Variables 2006 2007 2008 2009 2010 
Aver-
age*
P
0-14 yr Mean 4.64 4.57 4.69 4.83 4.79 4.70 0.144
A00-B99 2.09 2.04 2.35 2.56 2.56 2.31
C00-D48 9.01 9.10 9.69 9.56 9.30 9.33
D50-D89 6.48 5.92 5.53 5.62 5.01 5.71
G00-G99 2.72 2.71 2.52 2.45 2.85 2.65
I00-I99 3.57 4.07 3.93 4.06 4.50 4.03
J00-J99 2.45 2.63 2.25 2.17 2.67 2.43
K00-K93 2.39 2.78 2.94 3.41 2.99 2.90
M00-M99 3.68 3.58 4.04 5.02 5.29 4.32
N00-N99 3.37 2.49 2.84 3.29 3.51 3.11
O00-O99 1.75 2.00 2.00 1.80 2.00 1.91
Q00-Q99 2.90 2.78 3.08 2.95 2.98 2.94
S00-T98 2.48 2.96 2.78 3.29 2.86 2.87
Others 4.22 4.09 3.83 3.98 4.07 4.04
15-44 yr Mean 5.15 5.09 5.20 5.16 5.05 5.13 0.328
A00-B99 4.44 4.34 4.41 5.14 4.61 4.59
C00-D48 6.60 6.53 6.74 6.47 6.28 6.52
D50-D89 6.11 6.10 5.52 5.89 5.80 5.87
G00-G99 3.65 3.62 4.06 3.87 3.65 3.78
I00-I99 4.97 5.24 5.24 5.40 5.56 5.27
J00-J99 3.60 3.66 3.36 3.70 3.66 3.60
K00-K93 4.89 4.75 4.75 4.72 4.63 4.75
M00-M99 3.78 3.70 3.91 3.72 3.82 3.79
N00-N99 3.51 3.46 3.48 3.52 3.52 3.50
O00-O99 3.53 3.63 3.62 3.62 3.56 3.59
Q00-Q99 4.45 4.91 5.64 4.82 5.78 5.12
S00-T98 5.66 5.49 5.60 5.64 5.52 5.58
Others 3.57 3.41 3.79 4.34 4.06 3.85
P value by ANOVA test.
*Average of the number of red blood cell units transfused per recipient from 2006 to 2010 by age and disease classification; †See Table 1 for disease classi-
fication.
Variables 2006 2007 2008 2009 2010 
Aver-
age*
P
45-64 yr Mean 5.26 5.21 5.36 5.34 5.32 5.30 0.333
A00-B99 4.88 4.81 4.83 4.69 4.70 4.78
C00-D48 6.08 6.05 6.31 6.27 6.33 6.21
D50-D89 4.91 4.93 4.93 5.26 5.24 5.06
G00-G99 3.71 3.87 3.80 3.65 3.66 3.74
I00-I99 5.13 5.01 5.27 5.41 5.34 5.23
J00-J99 3.78 3.81 3.89 3.88 3.87 3.85
K00-K93 5.14 4.99 5.02 4.94 4.77 4.97
M00-M99 3.48 3.47 3.52 3.49 3.50 3.49
N00-N99 3.89 3.85 4.03 4.05 4.05 3.98
O00-O99 4.02 4.54 3.75 3.69 3.37 3.82
Q00-Q99 4.23 4.06 5.14 5.54 5.17 4.87
S00-T98 4.70 4.81 4.82 4.88 4.76 4.79
Others 3.41 3.46 3.81 3.98 4.40 3.84
≥65 yr Mean 4.52 4.49 4.59 4.59 4.58 4.56 0.887
A00-B99 3.85 3.76 3.71 3.69 3.57 3.70
C00-D48 5.45 5.43 5.53 5.59 5.65 5.54
D50-D89 4.75 4.39 4.37 4.46 4.43 4.47
G00-G99 3.21 3.21 3.31 3.29 3.36 3.28
I00-I99 4.19 4.14 4.49 4.47 4.51 4.37
J00-J99 3.26 3.24 3.29 3.28 3.28 3.27
K00-K93 4.04 3.95 4.01 4.04 3.91 3.99
M00-M99 3.71 3.71 3.81 3.84 3.86 3.80
N00-N99 3.87 3.79 3.91 3.85 3.79 3.84
O00-O99 0.00 2.00 0.00 0.00 0.00 2.00
Q00-Q99 5.06 4.57 4.67 4.60 6.03 4.99
S00-T98 3.51 3.53 3.60 3.54 3.54 3.55
Others 3.00 2.95 2.93 2.90 2.98 2.95
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Table 5. Number (%) of recipients of red blood cell units transfused from 2006 to 2010 by medical institution and disease classification†
Variables 2006 2007 2008 2009 2010 Average* P
Tertiary hospital Subtotal 119,295 (100) 121,518 (100) 131,483 (100) 139,104 (100) 143,256 (100) 130,931.2 (100) <0.001
A00-B99 2,787 (2.3) 2,793 (2.3) 3,139 (2.4) 3,202 (2.3) 3,564 (2.5) 3,097.0 (2.4)
C00-D48 44,996 (37.7) 45,759 (37.7) 49,720 (37.8) 52,924 (38.0) 54,341 (37.9) 49,548.0 (37.8)
D50-D89 3,007 (2.5) 3,111 (2.6) 3,457 (2.6) 3,813 (2.7) 3,792 (2.6) 3,436.0 (2.6)
G00-G99 1,336 (1.1) 1,324 (1.1) 1,533 (1.2) 1,461 (1.1) 1,566 (1.1) 1,444.0 (1.1)
I00-I99 16,352 (13.7) 16,452 (13.5) 17,716 (13.5) 18,284 (13.1) 18,990 (13.3) 17,558.8 (13.4)
J00-J99 3,381 (2.8) 3,592 (3.0) 4,074 (3.1) 4,688 (3.4) 4,716 (3.3) 4,090.2 (3.1)
K00-K93 14,213 (11.9) 14,383 (11.8) 14,798 (11.3) 15,706 (11.3) 15,732 (11.0) 14,966.4 (11.4)
M00-M99 10,373 (8.7) 10,963 (9.0) 12,388 (9.4) 13,317 (9.6) 13,740 (9.6) 12,156.2 (9.3)
N00-N99 7,609 (6.4) 7,764 (6.4) 8,861 (6.7) 9,840 (7.1) 10,192 (7.1) 8,853.2 (6.8)
O00-O99 3,451 (2.9) 3,718 (3.1) 3,448 (2.6) 3,514 (2.5) 3,883 (2.7) 3,602.8 (2.8)
Q00-Q99 3,203 (2.7) 3,161 (2.6) 3,161 (2.4) 2,877 (2.1) 2,879 (2.0) 3,056.2 (2.3)
S00-T98 8,874 (7.4) 8,916 (7.3) 9,848 (7.5) 10,498 (7.5) 11,047 (7.7) 9,836.6 (7.5)
Others 5,399 (4.5) 5,476 (4.5) 6,467 (4.9) 6,857 (4.9) 7,050 (4.9) 6,249.8 (4.8)
General hospital Subtotal 130,416 (100) 137,252 (100) 147,960 (100) 147,918 (100) 157,737 (100) 144,256.6 (100) <0.001 
A00-B99 3,864 (3.0) 4,108 (3.0) 4,679 (3.2) 4,841 (3.3) 5,714 (3.6) 4,641.2 (3.2)
C00-D48 32,579 (25.0) 34,326 (25.0) 36,339 (24.6) 34,401 (23.3) 36,716 (23.3) 34,872.2 (24.2)
D50-D89 5,077 (3.9) 5,275 (3.8) 5,767 (3.9) 6,002 (4.1) 6,394 (4.1) 5,703.0 (4.0)
G00-G99 1,189 (0.9) 1,237 (0.9) 1,384 (0.9) 1,351 (0.9) 1,479 (0.9) 1,328.0 (0.9)
I00-I99 16,462 (12.6) 17,254 (12.6) 18,475 (12.5) 17,741 (12.0) 18,476 (11.7) 17,681.6 (12.3)
J00-J99 6,024 (4.6) 6,579 (4.8) 7,818 (5.3) 8,105 (5.5) 9,133 (5.8) 7,531.8 (5.2)
K00-K93 20,216 (15.5) 21,642 (15.8) 22,836 (15.4) 22,547 (15.2) 23,341 (14.8) 22,116.4 (15.3)
M00-M99 16,038 (12.3) 17,337 (12.6) 19,164 (13.0) 20,203 (13.7) 21,104 (13.4) 18,769.2 (13.0)
N00-N99 10,136 (7.8) 10,790 (7.9) 11,828 (8.0) 12,678 (8.6) 13,658 (8.7) 11,818.0 (8.2)
O00-O99 3,414 (2.6) 3,389 (2.5) 3,056 (2.1) 2,7 (1.9) 2,880 (1.8) 3,097.4 (2.1)
Q00-Q99 769 (0.6) 786 (0.6) 784 (0.5) 935 (0.6) 934 (0.6) 841.6 (0.6)
S00-T98 16,384 (12.6) 16,842 (12.3) 18,709 (12.6) 19,534 (13.2) 21,503 (13.6) 18,594.4 (12.9)
Others 6,719 (5.2) 6,960 (5.1) 7,420 (5.0) 7,295 (4.9) 8,086 (5.1) 7,296.0 (5.1)
Hospital Subtotal 51,080 (100) 57,824 (100) 65,053 (100) 74,106 (100) 82,238 (100) 66,060.2 (100) <0.001
A00-B99 1,115 (2.2) 1,058 (1.8) 1,178 (1.8) 1,372 (1.9) 1,576 (1.9) 1,259.8 (1.9)
C00-D48 5,178 (10.1) 5,427 (9.4) 5,479 (8.4) 5,751 (7.8) 6,225 (7.6) 5,612.0 (8.5)
D50-D89 2,242 (4.4) 2,344 (4.1) 2,471 (3.8) 2,761 (3.7) 2,994 (3.6) 2,562.4 (3.9)
G00-G99 357 (0.7) 419 (0.7) 471 (0.7) 594 (0.8) 627 (0.8) 493.6 (0.7)
I00-I99 3,568 (7.0) 3,436 (5.9) 3,460 (5.3) 3,615 (4.9) 3,638 (4.4) 3,543.4 (5.4)
J00-J99 2,026 (4.0) 2,094 (3.6) 2,523 (3.9) 3,157 (4.3) 3,425 (4.2) 2,645.0 (4.0)
K00-K93 4,581 (9.0) 4,535 (7.8) 4,437 (6.8) 4,702 (6.3) 4,758 (5.8) 4,602.6 (7.0)
M00-M99 19,862 (38.9) 25,454 (44.0) 30,227 (46.5) 36,122 (48.7) 41,033 (49.9) 30,539.6 (46.2)
N00-N99 1,867 (3.7) 1,907 (3.3) 2,339 (3.6) 2,738 (3.7) 2,888 (3.5) 2,347.8 (3.6)
O00-O99 1,513 (3.0) 1,890 (3.3) 1,757 (2.7) 2,031 (2.7) 2,480 (3.0) 1,934.2 (2.9)
Q00-Q99 23 (0.0) 24 (0.0) 29 (0.0) 30 (0.0) 29 (0.0) 27.0 (0.0)
S00-T98 8,566 (16.8) 9,125 (15.8) 10,564 (16.2) 11,222 (15.1) 12,411 (15.1) 10,377.6 (15.7)
Others 2,237 (4.4) 2,500 (4.3) 2,698 (4.1) 3,002 (4.1) 3,397 (4.1) 2,766.8 (4.2)
(Continued to the next page)
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RBC units over the 5-yr period were patients with: neoplastic 
diseases (37.8%) and diseases of the circulatory system (13.4%) 
at tertiary hospitals (P <0.001); neoplastic diseases (24.2%) and 
diseases of the digestive system (15.3%) at general hospitals 
(P <0.001); and diseases of the musculoskeletal system and 
connective tissue (46.2%) and injury, poisoning, and other con-
sequences resulting from external causes (15.7%) at hospitals 
(P <0.001; Table 5). 
 Disease groups with the highest number of RBC units trans-
fused per recipient over the 5-yr period were: diseases of the 
blood and blood-forming organs and certain disorders involving 
the immune mechanism/system (7.43 units) and neoplastic dis-
eases (6.26 units) at tertiary hospitals (P =0.552); neoplastic dis-
eases (5.38 units) and diseases of the circulatory system (4.41 
units) at general hospitals (P =0.095); and neoplastic diseases 
(4.08 units) as well as diseases of the congenital malformations, 
deformations, and chromosomal abnormalities (4.02 units) at 
hospitals (P =0.107; Table 6).
Table 5. (continued from the previous page) Number (%) of recipients of red blood cell units transfused from 2006 to 2010 by medical in-
stitution and disease classification†
Variables 2006 2007 2008 2009 2010 Average* P
Long-term 
   care hospital 
Subtotal 4,164 (100) 7,540 (100) 2,705 (100) 3,566 (100) 3,903 (100) 4,375.6 (100) <0.001
A00-B99 192 (4.6) 321 (4.3) 792 (29.3) 1,227 (34.4) 1,288 (33.0) 764.0 (17.5)
C00-D48 697 (16.7) 1,315 (17.4) 233 (8.6) 231 (6.5) 322 (8.3) 559.6 (12.8)
D50-D89 92 (2.2) 162 (2.1) 48 (1.8) 62 (1.7) 65 (1.7) 85.8 (2.0)
G00-G99 261 (6.3) 427 (5.7) 41 (1.5) 77 (2.2) 78 (2.0) 176.8 (4.0)
I00-I99 1,330 (31.9) 2,102 (27.9) 217 (8.0) 233 (6.5) 240 (6.1) 824.4 (18.8)
J00-J99 546 (13.1) 1,054 (14.0) 1,182 (43.7) 1,522 (42.7) 1,628 (41.7) 1,186.4 (27.1)
K00-K93 179 (4.3) 355 (4.7) 34 (1.3) 49 (1.4) 48 (1.2) 133.0 (3.0)
M00-M99 98 (2.4) 172 (2.3) 18 (0.7) 14 (0.4) 18 (0.5) 64.0 (1.5)
N00-N99 145 (3.5) 388 (5.1) 90 (3.3) 183 (5.1) 261 (6.7) 213.4 (4.9)
O00-O99 6 (0.1) 2 (0.0) 1 (0.0) 0 (0.0) 0 (0.0) 1.8 (0.0)
Q00-Q99 3 (0.1) 1 (0.0) 0 (0.0) 1 (0.0) 0 (0.0) 1.0 (0.0)
S00-T98 131 (3.1) 229 (3.0) 23 (0.9) 29 (0.8) 18 (0.5) 86.0 (2.0)
Others 800 (19.2) 1,716 (22.8) 163 (6.0) 162 (4.5) 182 (4.70) 604.6 (13.8)
Private clinic Subtotal 8,896 (100) 9,115 (100) 8,720 (100) 8,313 (100) 8,766 (100) 8,762.0 (100) <0.001
A00-B99 34 (0.4) 32 (0.4) 10 (0.1) 22 (0.3) 23 (0.3) 24.2 (0.3)
C00-D48 1,017 (11.4) 942 (10.3) 860 (9.9) 890 (10.7) 929 (10.6) 927.6 (10.6)
D50-D89 325 (3.7) 390 (4.3) 425 (4.9) 423 (5.1) 440 (5.0) 400.6 (4.6)
G00-G99 17 (0.2) 16 (0.2) 14 (0.2) 16 (0.2) 12 (0.1) 15.0 (0.2)
I00-I99 170 (1.9) 140 (1.5) 115 (1.3) 121 (1.5) 97 (1.1) 128.6 (1.5)
J00-J99 60 (0.7) 45 (0.5) 45 (0.5) 33 (0.4) 25 (0.3) 41.6 (0.5)
K00-K93 213 (2.4) 221 (2.4) 176 (2.0) 166 (2.0) 164 (1.9) 188.0 (2.1)
M00-M99 3,171 (35.6) 3,359 (36.9) 3,270 (37.5) 2,658 (32.0) 2,398 (27.4) 2,971.2 (33.9)
N00-N99 1,093 (12.3) 1,075 (11.8) 1,195 (13.7) 1,256 (15.1) 1,289 (14.7) 1,181.6 (13.5)
O00-O99 1,966 (22.1) 2,233 (24.5) 2,036 (23.3) 2,246 (27.0) 2,852 (32.5) 2,266.6 (25.9)
Q00-Q99 8 (0.1) 7 (0.1) 6 (0.1) 2 (0.0) 3 (0.0) 5.2 (0.1)
S00-T98 673 (7.6) 564 (6.2) 551 (6.3) 468 (5.6) 519 (5.9) 555.0 (6.3)
Others 267 (3.0) 215 (2.4) 171 (2.0) 177 (2.1) 166 (1.9) 199.2 (2.3)
P value by Mantel-Haenszel Chi-square test. The subtotal is not calculated as 100 in this table because the same person could get the red blood cell units 
with different diseases.
*Average of the number of recipients (%) of red blood cell units transfused from 2006 to 2010 by medical institution and disease classification; †See Table 1 
for disease classification.
Kim V, et al.
Differences in RBC units transfused
340 www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.5.331
DISCUSSION
The highest numbers of both male and female RBC unit trans-
fusion recipients were aged ≥65 yr; this age group also had the 
highest increasing rate of RBC units transfused. Recipients with 
the highest number of RBC units transfused were female (gen-
der), aged >65 yr (age group), with health insurance (insurance 
type), and diagnosed with neoplastic diseases (disease group). 
Additionally, recipients with the highest number of RBC units 
transfused per recipient were male (gender), aged 45-64 yr (age 
group), with public medical aid (insurance type), and diagnosed 
with neoplastic diseases (disease group).
 This study found that the increase in the absolute number of 
RBC units transfused for recipients across disease groups from 
2006 to 2010 was the result of an increase in the number of 
transfusion recipients that is possibly due to the increased num-
ber of patients diagnosed with diseases that require RBC units. 
For instance, the number of recipients with neoplastic diseases 
Table 6. Number of red blood cell units transfused per recipient from 2006 to 2010 by medical institution and disease classification†
Variables 2006 2007 2008 2009 2010
Aver-
age*
P Variables 2006 2007 2008 2009 2010
Aver-
age*
P 
Tertiary 
   hospital
Mean 5.41 5.38 5.54 5.53 5.53 5.48 0.552 Hospital K00-K93 3.44 3.38 3.31 3.29 3.32 3.35 0.107
A00-B99 4.92 4.86 4.88 5.00 4.63 4.85 M00-M99 3.60 3.68 3.76 3.74 3.79 3.73
C00-D48 6.19 6.16 6.34 6.23 6.35 6.26 N00-N99 3.22 3.13 3.26 3.24 3.28 3.23
D50-D89 7.73 7.61 7.05 7.35 7.48 7.43 O00-O99 3.08 3.04 3.02 2.99 2.80 2.97
G00-G99 3.42 3.44 3.60 3.40 3.54 3.48 Q00-Q99 5.96 4.08 3.00 3.87 3.62 4.02
I00-I99 5.06 5.07 5.29 5.45 5.42 5.27 S00-T98 3.33 3.34 3.33 3.30 3.34 3.33
J00-J99 3.86 4.07 3.85 3.83 3.90 3.90 Others 2.83 2.88 2.80 2.88 2.78 2.83
K00-K93 5.06 4.92 4.98 4.83 4.56 4.86 Long-
   term 
   care 
   hospital 
Mean 3.47 3.42 2.85 2.98 2.92 3.20 0.003
M00-M99 3.89 3.80 3.91 3.95 3.91 3.90 A00-B99 2.72 2.77 2.92 2.94 2.89 2.90
N00-N99 3.71 3.73 3.79 3.76 3.76 3.75 C00-D48 3.92 3.78 2.81 3.03 3.21 3.61
O00-O99 4.00 4.27 4.21 4.31 4.41 4.24 D50-D89 3.51 3.39 3.00 2.82 2.88 3.21
Q00-Q99 3.28 3.22 3.75 3.69 3.76 3.53 G00-G99 2.96 2.89 2.66 2.70 2.69 2.87
S00-T98 5.07 5.05 5.25 5.03 4.86 5.04 I00-I99 3.15 3.14 2.50 2.49 2.55 3.04
Others 3.73 3.65 3.78 4.14 4.36 3.96 J00-J99 2.90 2.82 2.64 2.69 2.58 2.69
General 
   hospital
Mean 4.51 4.43 4.54 4.53 4.50 4.50 0.095 K00-K93 3.25 3.05 2.56 2.88 2.60 3.03
A00-B99 3.95 3.88 3.88 3.99 3.88 3.91 M00-M99 2.99 2.79 2.61 2.57 2.33 2.81
C00-D48 5.35 5.29 5.44 5.45 5.38 5.38 N00-N99 2.92 3.08 2.77 2.99 2.95 2.99
D50-D89 4.55 4.25 4.20 4.40 4.25 4.33 O00-O99 2.83 2.00 2.00 0.00 0.00 2.56
G00-G99 3.25 3.49 3.47 3.39 3.48 3.42 Q00-Q99 2.33 1.00 0.00 3.00 0.00 2.20
I00-I99 4.32 4.25 4.53 4.46 4.48 4.41 S00-T98 3.10 2.82 2.43 3.00 2.67 2.89
J00-J99 3.25 3.14 3.32 3.33 3.33 3.28 Others 3.23 3.03 2.38 2.78 2.47 3.00
K00-K93 4.25 4.11 4.13 4.16 4.09 4.15 Private 
   clinic
Mean 3.12 3.13 3.17 3.15 3.05 3.12 0.552
M00-M99 3.52 3.44 3.54 3.54 3.57 3.53 A00-B99 2.53 2.28 2.00 2.36 3.30 2.54
N00-N99 3.78 3.66 3.79 3.82 3.76 3.76 C00-D48 3.36 3.35 3.34 3.34 3.16 3.31
O00-O99 3.51 3.52 3.56 3.53 3.47 3.52 D50-D89 2.98 2.93 2.80 3.01 3.03 2.95
Q00-Q99 3.32 3.17 3.58 3.04 3.55 3.33 G00-G99 2.18 2.13 3.00 2.56 3.33 2.59
S00-T98 3.93 3.94 3.91 3.96 3.90 3.93 I00-I99 2.81 2.89 3.06 2.64 2.82 2.84
Others 3.11 3.06 3.13 3.04 3.21 3.11 J00-J99 2.55 2.18 2.60 2.52 2.16 2.43
Hospital Mean 3.61 3.63 3.65 3.64 3.64 3.64 0.107 K00-K93 2.85 2.76 3.01 3.19 2.84 2.92
A00-B99 3.06 2.98 2.91 2.81 2.85 2.91 M00-M99 3.31 3.32 3.33 3.32 3.25 3.31
C00-D48 4.24 4.16 4.08 4.12 3.86 4.08 N00-N99 3.10 3.23 3.25 3.30 3.27 3.23
D50-D89 3.41 3.38 3.25 3.24 3.31 3.31 O00-O99 2.76 2.79 2.79 2.78 2.71 2.76
G00-G99 3.21 3.04 2.87 3.12 2.84 3.00 Q00-Q99 3.13 3.00 3.33 4.00 2.67 3.15
I00-I99 3.29 3.18 3.13 3.07 3.01 3.14 S00-T98 2.92 2.77 2.77 2.72 2.74 2.79
J00-J99 2.71 2.75 2.75 2.76 2.81 2.76 Others 2.67 2.75 3.06 2.58 2.66 2.74
P value by ANOVA test.
*Average of the number of red blood cell units transfused per recipient from 2006 to 2010 by medical institution and disease classification; †See Table 1 for 
disease classification.
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increased from 80,485 in 2006 to 93,961 in 2010, and the num-
ber of recipients with diseases of the musculoskeletal system 
and connective tissue increased from 49,350 in 2006 to 77,990 
in 2010. Although the number of RBC units transfused per re-
cipient did not change significantly between 2006 and 2010 
within each disease group, it increased from 6.01 units in 2006 
to 6.09 units in 2010, and from 3.63 units in 2006 and 3.76 units 
in 2010 for recipients with neoplastic diseases and diseases of 
the musculoskeletal system and connective tissue, respectively.
 The total average compositional rates for RBC units trans-
fused over the 5-yr period were 31.9% for neoplastic diseases; 
14.4% for diseases of the musculoskeletal system and connec-
tive tissue; 11.2% for diseases of the circulatory system; 11.0% 
for diseases of the digestive system; and 9.6% for injury, poison-
ing, and certain other consequences of external causes. These 
results are similar to those observed by the PROTON study con-
ducted in Netherlands, where the following compositional rates 
were reported: 21.5% for diseases of the circulatory system; 
22.2% for neoplastic diseases; 10.5% for injury, poisoning, and 
certain other consequences of external causes; 9.8% for dis-
eases of the digestive system; and 5.3% for diseases of the 
musculoskeletal system and connective tissue [10]. 
 In addition, transfusion recipient numbers by medical institu-
tion type were different depending on disease types. This dem-
onstrates that the distribution of patient groups requiring RBC 
unit transfusion varies based on the institution type. Therefore, 
we could suggest that the increase in the total number of RBC 
units transfused could be explained by the involvement of spe-
cialized hospitals, the increase in the number of patients diag-
nosed with cancer or diseases of the musculoskeletal system 
and connective tissue, or the increase in the number of surgery 
procedures associated with these diseases. For instance, be-
tween 2006 and 2010, the number of hospitalized patients in-
creased: from 605,462 (14.0%) to 890,857 (15.6%) for injury, 
poisoning and other consequences resulting from external 
causes; from 549,887 (11.3%) to 644,132 (11.3%) for diseases 
of the circulatory system; from 375,516 (8.7%) to 506,311 (8.9%) 
for neoplastic diseases; and from 336,247 (7.7%) to 637,385 
(11.2%) for diseases of the musculoskeletal system and con-
nective tissue, respectively [15, 16]. 
 We found that transfusion recipients were more commonly 
women than men. Moreover, more than 50% of recipients were 
aged ≥65 yr, and they used 40% of the total transfused blood 
volume. The increased demand for RBC units is the result of 
changes in population structure as well as increased number of 
patients at risk. The percentage of people aged ≥65 yr increased 
from 9.5% in 2006 to 11.0% in 2010; additionally, women repre-
sented 66.7% of the population in 2006, compared to 69.2% in 
2010 [17]. Furthermore, women’s concern for their health has 
increased, which has led them to visit hospitals more frequently 
[18]. Several previous studies showed that the elderly use a sig-
nificant amount of blood components. For instance, elderly pa-
tients constituted 40% of the total RBC recipients in 1999 in the 
United Kingdom [6]. People aged ≥70 yr accounted for 39.9% 
of the total RBC unit consumption in 2004 in Mecklenburg-
Western Pomerania [8]. Moreover, recipients aged ≥65 yr re-
ceived 57.6% of the RBC units, 41.4% of the fresh frozen plasma 
(FFP) units, and 29.0% of the platelet (PLT) units from 1996 to 
2006 in the Netherlands [10]. In our study, we also observed that 
men required more RBC units transfused. This may be attribut-
able to men undergoing more aggressive treatments than 
women, requiring more excessive blood transfusions. This ob-
servation was similarly reported by a study conducted in the 
Netherlands, where 50% of all RBC units, 59% of all FFP units, 
and 60% of all PLT units were transfused to men [10].
 The decision to transfuse RBC components depends on the 
amount of blood loss, hemoglobin levels, and other patient clini-
cal criteria used by doctors to determine the need to provide 
sufficient oxygen to patients’ peripheral parts or tissues. How-
ever, the increase in the number of transfusion recipients and of 
transfused RBC units observed in our study suggests that some 
other issues should be considered during the decision process, 
such as whether the transfusion is necessary, and whether the 
appropriate amount of blood is transfused to avoid overtransfu-
sion [19].
 Comparison between studies is rarely beneficial, due to differ-
ences in study timeframes, practice guidelines, design, and 
particularly, due to the influence of appropriateness criteria. 
However, 2 systematic reviews have considered 4-66% of trans-
fusion recipients to be inappropriate recipients [20, 21], and 
previous reports suggested that 20-51.5% of transfusion recipi-
ents were overtransfused [22, 23]. In the present study, we were 
unable to determine patient health conditions; therefore, we 
could not determine whether the transfusion was necessary or 
whether the appropriate number of RBC units was transfused. 
The HIRA has evaluated the number and appropriateness of 
transfusions conducted by general and tertiary hospitals since 
2003, and has published the evaluation [24]. However, this as-
sessment did not lead to a regulation of the demand for blood 
units at these hospitals. 
 This study has some limitations. First, our analysis was based 
on the primary discharge diagnosis, although diagnoses may 
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have been exaggerated or falsified for the insurance claim. In 
addition, our findings did not include data involving non-primary 
diseases. Second, we did not consider the recipient clinical sta-
tus, since it could not be determined using the claim data. As a 
result, we could not identify whether the RBC units were appro-
priately or inappropriately transfused. The increasing rates we 
observed suggest overuse, although it is possible that patient 
conditions were getting worse, or that more surgical procedures 
requiring larger volume blood transfusions were performed; this 
issue can be clarified through reviewing the medical records of 
recipients. Third, blood unit claims from occupational insur-
ance, car insurance, and the non-insurance sector were not in-
cluded in our study. Furthermore, we were unable to distinguish 
between donor blood and autologous blood use at the various 
institutions. Finally, we were only able to examine general recipi-
ent characteristics (gender, age, and disease) but not other re-
cipient health-related variables or characteristics of the doctor 
who made the decision to use RBC units.
 Future studies should investigate the causes behind this in-
crease in the number of RBC unit recipients and should thor-
oughly examine transfusion recipients’ medical records to as-
sess the appropriateness of transfusions.
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